Seagen's (SGEN) Cancer Drugs Aid Growth, Stiff Rivalry a Woe

Seagen's (SGEN) Cancer Drugs Aid Growth, Stiff Rivalry a Woe

Source: 
Yahoo/Zacks.com
snippet: 

Seagen Inc. is making good progress with its portfolio of marketed drugs — Adcetris, Padcev, Tukysa and the newly approved Tivdak — targeting different types of cancer indications.